Primary Objectives:
• To determine the feasibility of implementing a chatbot-facilitated remote informed consent (IC) process.
Secondary Objectives
* To identify determinants of patient acceptance and usage of the chatbot.
* To determine the accuracy and completeness of information delivered via the chatbot.
* To determine the quality of the chatbot-facilitated remote IC process.
* To determine the feasibility of using the chatbot for patient eligibility verification.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Ability to understand and willingness to provide informed consent.
Age ≥18 years.
Patients whose preferred language is English.
Patients who are being considered for enrollment in selected clinical research studies.
Phase I will be initiated using the Clearinghouse protocol PA11-0852, a non-interventional biomarker study.
You may not be if
N/A
Clareo Health | Chatbot Implementation In The Clinical Informed Consent Process
